Design Therapeutics (DSGN) to Release Earnings on Tuesday

Design Therapeutics (NASDAQ:DSGN) will likely be issuing its quarterly earnings data before the market opens on Tuesday, March 18th. Analysts expect the company to announce earnings of ($0.27) per share for the quarter.

Design Therapeutics (NASDAQ:DSGN) last released its quarterly earnings results on Monday, March 10th. The company reported ($0.24) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.04. On average, analysts expect Design Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Design Therapeutics Price Performance

DSGN stock opened at $4.70 on Monday. The business has a fifty day moving average price of $4.76 and a 200 day moving average price of $5.36. Design Therapeutics has a fifty-two week low of $2.45 and a fifty-two week high of $7.77. The stock has a market capitalization of $266.79 million, a price-to-earnings ratio of -5.53 and a beta of 1.77.

About Design Therapeutics

Design Therapeutics, Inc a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion.